Sphera Funds Management Ltd. has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $545 Million distributed in 116 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Teva Pharmaceutical Industries LTD with a value of $38.4M, Sanofi with a value of $23.6M, Bridge Bio Pharma, Inc. with a value of $21.5M, Syndax Pharmaceuticals Inc with a value of $19.9M, and Amazon Com Inc with a value of $19.7M.

Examining the 13F form we can see an decrease of $138M in the current position value, from $683M to 545M.

Sphera Funds Management Ltd. is based out at Tel Aviv, L3

Below you can find more details about Sphera Funds Management Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $545 Million
Healthcare: $376 Million
Technology: $126 Million
Consumer Cyclical: $22.2 Million
Communication Services: $16.8 Million
Basic Materials: $1.96 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 116
  • Current Value $545 Million
  • Prior Value $683 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 20 stocks
  • Additional Purchases 27 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 40 stocks
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.